Akoustis Technologies Inc reports results for the quarter ended in March - Earnings Summary

Aktis Oncology

02/05/2022 14:31

* Akoustis Technologies Inc  AKTS.OQ  reported a quarterly
adjusted loss of 22 cents​​ per share for the quarter ended in
March. The mean expectation of four analysts for the quarter was
for a loss of 22 cents per share.
    * Revenue rose 83% to $4.61 million from a year ago; 
analysts
expected $4.70 million. 
    * Akoustis Technologies Inc's reported EPS for the quarter
was a
loss of 27 cents​.
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Akoustis Technologies Inc shares had fallen by 31.7% this
quarter and lost 33.5% so far this year.
    * The company reported a quarterly loss of $14.68 million.
    * Wall Street's median 12-month price target for Akoustis
Technologies Inc is $11.25 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated May 2 at 01:30 p.m.  ​All
figures in US dollars unless otherwise stated